SCHEMBL3736113

SCHEMBL3736113

COc1cncn1Cc1ccccc1CC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
CYP11B1 P15538 3/20 0.41
CYP11B2 P19099 3/20 0.41
AKR1B1 P15121 1/20 0.39
MMP2 P08253 4/20 0.39
MMP12 P39900 4/20 0.39
MMP8 P22894 3/20 0.39
MMP13 P45452 3/20 0.39
MMP14 P50281 3/20 0.39
MMP16 P51512 3/20 0.39
MMP9 P14780 3/20 0.37
MMP1 P03956 1/20 0.36
MMP3 P08254 1/20 0.36
BRD4 O60885 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049173 0.88 CYP11B1 (0.46) CYP19A1CYP11B1CYP11B2HSD17B10KDM4E
SCHEMBL3736357 0.79 CYP19A1 (0.48) CYP19A1CYP11B1CYP11B2AKR1B1TDP1
SCHEMBL28179114 0.76 CYP11B1 (0.56) CYP11B1CYP11B2L3MBTL1
SCHEMBL13048283 0.73 CYP11B1 (0.47) CYP19A1CYP11B1CYP11B2ALDH1A1
SCHEMBL3733246 0.70 CYP19A1 (0.54) CYP19A1CYP11B1CYP11B2AKR1B1BRD4
Iodide SCHEMBL31305035 0.70 AKR1B1 (0.73) CYP19A1AKR1B1MMP2MMP12MMP8
Methyl Alcohol SCHEMBL28299530 0.68 AKR1B1 (0.70) CYP19A1AKR1B1MMP2MMP12MMP8
SCHEMBL30359 0.68 AKR1B1 (0.76) AKR1B1MMP2MMP12MMP8MMP13
SCHEMBL29410826 0.68 AKR1B1 (0.76) AKR1B1MMP2MMP12MMP8MMP13
SCHEMBL8954196 0.68 CYP11B1 (0.53) CYP11B1CYP11B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010142652-A1 IMIDAZOBENZAZEPINE COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) DISEASES GLAXO GROUP LIMITED (GB) 2010-12-16 WO disclosed